Once Again, Pharma Dominates The IPO Slate By: Benzinga via Benzinga September 27, 2017 at 08:23 AM EDT Apparently biotech is where it’s at. This year’s expansive class of newly public pharmaceuticals will add three to its ranks ... Read More >> Related Stocks: Renaissance International IPO ETF Roku Inc SPDR S&P 500 ETF Trust Standard & Poors 500